Bausch Health Chooses New Advisors Amid Ongoing Debt Sale Negotiations

Bausch Health Companies Inc., a prominent player in the pharmaceutical sector, has made a strategic decision to appoint new financial advisors after years of discussions surrounding an imminent debt sale. This shift comes as the company continues to navigate a complex financial landscape marked by significant challenges and restructuring efforts aimed at stabilizing its operations and enhancing its financial health.

Continue reading